Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Editorial: Lactobacillus GG for Diarrhoea in Children-Reports of Its Demise Have Been Premature!

Alimentary Pharmacology and Therapeutics

English

Letter: Eluxadoline-Associated Acute Pancreatitis-Myth or Reality? Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Editorial: Antigenic Response to CT-P13 and Infliximab Originator in IBD Shows Similar Epitope Recognition-Evidence From Basic Science Supports Safe Switching to Biosimilars. Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Editorial: Hepatitis C Virus (HCV) Disease Progression - HCV Cure and the Elimination of the “Ethnic Slope”

Alimentary Pharmacology and Therapeutics

English

Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab

Alimentary Pharmacology and Therapeutics

English

Smoking at Diagnosis Significantly Decreases 5-Year Cancer-Specific Survival in a Population-Based Cohort of 18 166 Colon Cancer Patients

Alimentary Pharmacology and Therapeutics

English

Issue Information

Alimentary Pharmacology and Therapeutics

English

Editorial: ONO-2952 in Irritable Bowel Syndrome With Diarrhoea - Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Risk of Developing Hepatocellular Carcinoma in Untreated HBeAg-negative Chronic Hepatitis B Patients With High Viral Load and No Significant ALT Elevation. Authors' Reply

Alimentary Pharmacology and Therapeutics

English

Issue Information

Alimentary Pharmacology and Therapeutics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Editorial: Lactobacillus GG for Diarrhoea in Children-Reports of Its Demise Have Been Premature!

Letter: Eluxadoline-Associated Acute Pancreatitis-Myth or Reality? Authors’ Reply

Editorial: Antigenic Response to CT-P13 and Infliximab Originator in IBD Shows Similar Epitope Recognition-Evidence From Basic Science Supports Safe Switching to Biosimilars. Authors’ Reply

Editorial: Hepatitis C Virus (HCV) Disease Progression - HCV Cure and the Elimination of the “Ethnic Slope”

Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab

Smoking at Diagnosis Significantly Decreases 5-Year Cancer-Specific Survival in a Population-Based Cohort of 18 166 Colon Cancer Patients

Issue Information

Editorial: ONO-2952 in Irritable Bowel Syndrome With Diarrhoea - Authors’ Reply

Letter: Risk of Developing Hepatocellular Carcinoma in Untreated HBeAg-negative Chronic Hepatitis B Patients With High Viral Load and No Significant ALT Elevation. Authors' Reply

Issue Information